Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity Relationships
C. R. M. Asquith, M. P. East, T. Laitinen, C. Alamillo-Ferrer, E. Hartikainen, C. I. Wells, A. D. Axtman, D. H. Drewry, G. J. Tizzard, A. Poso, T. M. Willson, G. L. Johnson
Abstract
The oxindole scaffold has been the center of several kinase drug discovery programs, some of which have led to approved medicines. A series of two oxindole matched pairs from the literature were identified where TLK2 was a potent off-target kinase. The oxindole as long been considered a promiscuous inhibitor template, but across these 4 specific literature oxindoles TLK2 activity was consistent, while the kinome profile was radically different from narrow to broad spectrum coverage. We synthesized a large series of analogues and through quantitative structure-activity relationship (QSAR) analysis, water mapping of the kinase ATP binding sites, small-molecule x-ray structural analysis and kinome profiling, narrow spectrum, sub-family selective, chemical tool compounds were identified to enable elucidation of TLK2 biology.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Design and analysis of the 4-anilino-quin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure activity relationships
C. R. M. Asquith, T. Laitinen, … A. Poso·bioRxiv·Sep 5, 2019
- Polypharmacology is an enduring and nearly universal property of kinase inhibitors
Caitlin E. Mills, Clemens B. Hug, … Peter Karl Sorger·bioRxiv·Apr 30, 2026
- Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco A. Greco, Andreas Krämer, … Stefan Knapp·European Journal of Medicinal ChemistryPeer-reviewed·Jul 14, 2024
- Allosteric inhibition of Aurora-A kinase by a synthetic VNAR nanobody
Selena G Burgess, Arkadiusz Oleksy, … Richard Bayliss·Open BiologyPeer-reviewed·Jul 1, 2016
- Discovery of an IKK2 Site that Allosterically Controls Its Activation
S. J. Hotchkiss, M. C. Mulero, … G. Ghosh·bioRxiv·Jan 27, 2021
- Development of Narrow Spectrum ATP-competitive Kinase Inhibitors as Probes for BIKE and AAK1
Rafael M. Couñago, Alison D. Axtman, … William J. Zuercher·bioRxiv·Mar 2, 2017